Lates News

date
11/09/2025
Hong Kong-listed innovative pharmaceutical concepts continue to decline, with Gleich Pharmaceuticals falling over 14% and China Biopharmaceuticals falling over 9%. BeiGene and Shiyao Group also followed the decline.